Event BIO-Europe 2017

October 16, 2017

Date : November 6–8, 2017
Location : Berlin, Germany
Jinhan Kim, Standigm CEO will speak at the Bio-Europe 2017 on November 7, 2017. Sang Ok Song, Standigm COO will also attend the meeting. Meet them in Berlin.

News Standigm agrees partnership with KIST to discover a new drug for Autism

September 13, 2017

Standigm and Korea institute of science and technology (KIST) announced a research collaboration to develop a new small molecule medicine for Autism. The drug candidates chosen by Standigm’s AI drug discovery technology will validate experimentally by using KIST’s animal models.

News CrystalGenomics, a partner biopharmaceutical company of Standigm, finds first evidence to a new AI-driven drug for cancer.

August 29, 2017

CrystalGenomics, Inc., Standigm’s partner company, today announced a drug predicted by Standigm’s artificial intelligence technology showed the evidence that it may reuse for cancer treatment. The drug is an FDA-proved drug for other therapeutic uses. It has been only three months to sign the partnership between Standigm, Inc. and CrystalGenomics, Inc.